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Abstract
Problem—Decidual macrophages (dMϕ) of the mother and placental macrophages (Hofbauer
cells, HC) of the fetus are deployed at a critical location: the feto-maternal interface. This study
was conducted to compare DNA methylome of maternal and fetal monocytes, dMϕ, and HC, and
thereby to determine the immunobiological importance of DNA methylation in pregnancy.
Methods of Study—Paired samples were obtained from normal pregnant women at term not in
labor and their own neonates. Maternal monocytes (MM) and fetal monocytes (FM) were isolated
from peripheral blood of mothers and from fetal cord blood, respectively. dMϕ and HC were
obtained from the decidua of fetal membranes and placenta, respectively. DNA methylation
profiling was done using the Illumina Infinium Human Methylation27 BeadChip. Quantitative
real-time PCR and western blot were performed for validation experiments.
Results—1) Significant differences in DNA methylation were found in each comparison (MM
vs. FM, 65 loci; dMϕ vs. HC, 266 loci; MM vs. dMϕ, 199 loci; FM vs. HC, 1,030 loci). 2) Many
of the immune response-related genes were hypermethylated in fetal cells (FM and HC) compared
to maternal cells (MM and dMϕ). 3) Genes encoding markers of classical macrophage activation
were hypermethylated and genes encoding alternative macrophage activation were
hypomethylated in dMϕ and HC compared to MM and FM, respectively. 4) mRNA expressions of
DNMT1, DNMT3A, and DNMT3B were significantly lower in dMϕ than in HC. 5) 5-azacytidine
treatment increased expression of INCA1 in dMϕ.
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Conclusions—The findings herein indicate that DNA methylation patterns change during
monocyte-macrophage differentiation at the feto-maternal interface. It is also suggested that DNA
methylation is an important component of biological machinery conferring an anti-inflammatory
phenotype to macrophages at the feto-maternal interface.
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Placenta; Pregnancy
Introduction
Macrophages play key roles in immune responses against a wide variety of insults such as
infection1–3 and allograft rejection.4, 5 Human pregnancy is considered an immunologic
enigma since the semi-allogeneic fetal graft is accepted and tolerated during the course of
pregnancy.6–8 The mechanisms proposed for immunological tolerance to the fetus include
the expression of non-classical HLA molecules on trophoblasts,9, 10 changes in tryptophan
metabolism by indoleamine 2,3-dioxygenase,11, 12 and regulatory T cells.13–21 Placental
development, ranging from trophoblast invasion to deportation of trophoblast debris into
intervillous maternal circulation, is associated with the changes in the frames of feto-
maternal immune interaction.22–27 Therefore, the human placenta is at the epicenter of the
feto-maternal interface, and maternal cells of the decidua interact direct with fetal cells,
typically trophoblasts, beginning at the time of implantation and continuing throughout
pregnancy.15, 28–31 Maternal decidual macrophages (dMϕ) and fetal placental macrophages
(Hofbauer cells, HC), are important cell populations at the feto-maternal interface.32–39
They interact continuously with potential immunological signals (microbial or danger
signals)40, 41 and cells from the fetus and the mother.42–49 These two types of macrophages
(dMϕ and HC) are known to originate from maternal and fetal blood monocytes although
chorionic mesenchymal cells have been proposed as a major source of HC before the
formation of villous stromal capillaries.50, 51 Changes in the immunophenotype, metabolic
characteristics, and distribution of peripheral monocytes and dMϕ have been implicated in
the pathogenesis of pregnancy disorders such as preeclampsia,52–56 preterm labor with intact
membranes,57 preterm premature rupture of membranes,58 fetal systemic
inflammation,2, 59–61 and pyelonephritis.62 HC have been implicated in the pathogenesis of
pregnancy complications63 and they are activated in the presence of placental lesions
consistent with maternal anti-fetal cellular rejection.64, 65
DNA methylation is a prototypic example of epigenetic regulation of gene expressions along
with small non-coding RNA and histone tail modifications.66–69 DNA methylation largely
involves the cytosine residues of CpG dinucleotides in mammalian cells, and
hypermethylation leads to the decreased expression of the genes as seen in several tumor
suppressor genes during carcinogenesis.70, 71 DNA methylation is mediated by a family of
DNA methyltransferases (DNMT1, DNMT3A, DNMT3B),72, 73 and is important in various
cellular processes such as differentiation,74 transcription of genes,75 and genomic
imprinting.76 Recent studies have demonstrated associations between placental DNA
methylation patterns and pregnancy disorders. An analysis of 1,505 CpG sites revealed
hypomethylation of 34 loci including the promoter region of TIMP3 in early-onset
preeclampsia cases compared to control subjects.77 It was also shown that hypomethylation
of the H19 promoter region is associated with increased H19 expression in the placentas of
fetal growth restriction cases.78 However, considering the heterogeneity of placental cell
types and cell type specificity of DNA methylation patterns,79 the procurement of specific
cell populations would be important in the comparative analysis of DNA methylation
patterns in the placenta.
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DNA methylation has been shown to be important in the differentiation of hematopoietic
progenitor cells, and a subset of genes involved in differentiation is hypomethylated in
monocytes and granulocytes during hematopoiesis.80 Ji et al also have described drastic
alterations of DNA methylation with lymphoid and myeloid restriction from their progenitor
cells during hematopoiesis.81 These findings indicate that the changes in CpG methylation
are very important in lineage-specific hematopoietic cell differentiation. Tissue
macrophages are mainly derived from peripheral blood monocytes to meet the local needs.82
We hypothesized that distinct changes in DNA methylation occur during differentiation of
maternal monocytes (MMo) into dMϕ and during differentiation of fetal monocytes (FMo)
into HC, and differential DNA methylation patterns will give clues for further understanding
of the immunological characteristics of these cells during human pregnancy.
In the present study, we have compared the DNA methylome of MMo, FMo, dMϕ, and HC
using paired sets of samples and thereby to determine the immunobiological importance of
DNA methylation in normal pregnancy.
Materials and Methods
Study Design
The study was designed to compare the DNA methylome of MMo, FMo, dMϕ, and HC. The
paired samples were obtained from normal pregnant women at term not in labor and their
own babies (n=26) enrolled to the bank of biological materials of the Perinatology Research
Branch, Eunice Kennedy Shriver National Institute of Child Health and Human
Development, National Institute of Health, USA. Peripheral blood of mothers was collected
by venipuncture when admitted for cesarean section, and fetal cord blood was collected
from the umbilical vein during cesarean section. The placentas were used to obtain decidual
and villous macrophages. The numbers of paired samples used in the different experiments
are as follows: Infinium methylation assay (n=6), pyrosequencing (n=6), quantitative RT-
PCR (n=5), immunoblotting (n=4), dMϕ culture with 5-azacytidine treatment (n=5), and
BrdU assay (n=4). Samples isolated by flow sorting were used for Infinium methylation
assay and pyrosequencing, which require more pure cell populations. Faster cell column
isolation was used for quantitative RT-PCR, immunoblotting, and cell culture in order to
obtain more fresh samples in spite of relatively lower purity. Participating women provided
written informed consent, and the collection and use of the samples and clinical data for
research purposes were approved by the Institutional Review Boards of Wayne State
University and the Eunice Kennedy Shriver National Institute of Child Health and Human
Development, National Institutes of Health, U.S. Department of Health and Human
Services.
Isolation of blood monocytes by flow cytometric cell sorting
Peripheral blood mononuclear cells (PBMCs) were isolated from maternal and fetal cord
blood in EDTA by discontinuous density gradient centrifugation using Histopaque 1077
(Sigma-Aldrich, St. Louis, MO, USA). PBMCs were stained with phycoerythrin (PE)-Cy7-
conjugated anti-CD14, and allophycocyanin (APC)-conjugated anti-CD15 (BD Biosciences,
San Jose, CA, USA; for each). CD14+CD15- monocytes were sorted using a FACS Aria™
Cell Sorter (BD Biosciences), while CD14dim+CD15+ neutrophils and the other unstained
cells were negatively selected.
Isolation of tissue macrophages by flow cytometric sorting
For isolation of dMϕ, decidual tissue (7 gm), procured by scraping the decidual side of the
chorion and followed by mincing with a razor blade, was incubated in 50 ml of RPMI 1640
(Invitrogen, Carlsbad, CA, USA) containing 10% FBS and Dispase (2 mg/ml; Invitrogen) at
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37 °C for 30 min with shaking (175 rpm). Then the samples were centrifuged at 600 × g for
5 min, and the pellets were resuspended and incubated in 50 ml of RPMI 1640 containing
type IV collagenase (2 mg/ml; Worthington Biochemical Corporation, Lakewood, NJ,
USA), hyaluronidase (2 mg/ml; Sigma-Aldrich), and DNase I (50 μg/ml; Roche, Mannheim,
Germany) for 30 min at 37°C with shaking. The digest was homogenized using a syringe
with a 20-gauge needle, and incubated for an additional 30 min at 37°C with shaking (175
rpm). After filtering through the gauze and 100-micron nylon mesh, the digests were washed
2 times with DPBS and the cell numbers were counted. Antibody labeling and cell sorting
were performed as described above for blood monocytes.
For isolation of HC, the basal plate, the chorionic plate, and grossly visible blood vessels
were removed from the placental tissue. After 3 washes with DPBS, 7 gm of villous tissues
were used for a four-stage digestion protocol to isolate single cells from villous tissue.83
First, 50 ml of collagenase type 1A (0.624 mg/ml; Sigma-Aldrich) solution containing 0.684
mg/ml of hyaluronidase (Sigma-Aldrich), 0.12 mg/ml of DNase I (Roche), and 1 mg/ml of
BSA (Sigma-Aldrich) in DPBS was added to the tissue. Following incubation for 6 min at
37°C with shaking (175 rpm), the tubes were kept on ice for 5 min and supernatant was
discarded. For the second stage, 50 ml of trypsin solution (0.25 %, Invitrogen) containing
0.12 mg/ml of DNase I (Roche) and 0.5 mM of EDTA (pH 8.0, Invitrogen) were added and
incubated at 37°C for 30 min with shaking (175 rpm). The tissue digest was centrifuged at
600×g for 5 min, and the pellet was then incubated with collagenase type IV (2 mg/ml;
Worthington) in 50 ml of RPMI 1640 (10% FBS without antibiotics) containing 2 mg/ml of
hyaluronidase (Sigma-Aldrich), and 50 μg/ml of DNase I (Roche) at 37°C for 30 min with
shaking (175 rpm). The tissue digest was centrifuged at 600×g for 5 min and the supernatant
was removed. Finally, collagenase type IV treatment was repeated. Following the digestion
process, tissue digest was homogenized using a syringe with a 20-gauge needle, and
incubated for an additional 30 min at 37°C with shaking. This digest was filtered and
washed according to the same procedure used for decidual cell isolation as described above.
Antibody labeling and cell sorting were performed as described above for blood monocytes.
Monocyte and macrophage isolation using a separation column
Monocytes and macrophages were isolated using cell separation columns. PBMCs of
maternal blood and fetal cord blood were isolated by discontinuous density gradient
centrifugation using Histopaque 1077 (Sigma-Aldrich). After lysing the red blood cells with
sterile 0.2 % NaCl (pH 6.75) for 45 s, the cells were restored with sterile 1.6 % NaCl (pH
6.75) and centrifuged at 300 ×g for 5 min. Monocytes were isolated using Monocyte
Isolation Kit II and MS columns (Miltenyi Biotech Inc., Auburn, CA, USA) according to the
manufacturer’s instructions. A small fraction of isolated monocytes were stained with APC-
conjugated CD14 for the flow cytometric assessment of purity.
For isolation of dMϕ and HC, isolated single cells obtained by the protocols described above
were incubated with sterile 0.2 % NaCl (pH 6.75) for 45 s and restored with sterile 1.6 % of
NaCl (pH 6.75). Following removal of dead cells using a Dead Cell Removal Kit (Miltenyi
Biotech), macrophages were isolated by CD14 microbeads and LS columns (Miltenyi
Biotech). A small fraction of isolated macrophages were stained with APC-conjugated
CD14 for flow cytometry.
Confirmation of isolated monocytes and macrophages
Each population of positively sorted cells was reanalyzed by flow cytometry to evaluate the
purities of monocytes and macrophages. For visualization of the sorted CD14+ monocytes
and macrophages in a few representative cases, positively selected PE-Cy7-conjugated anti-
CD14+ cells were smeared on silanized slides, and mounted with Prolong Gold Antifade
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Reagent with DAPI (Invitrogen). The cells were examined using a Leica TCS SP5 spectral
confocal system (Leica Microsystems, Wetzler, Germany).
Infinium methylation assay
Genomic DNA of sorted MMo, FMo, dMϕ, and HC from women at term not in labor (n=6)
was isolated using a QIAamp DNA FFPE Tissue Kit (Qiagen, Valencia, CA, USA). DNA
(500 ng) samples were bisulfite modified using an EZ DNA Methylation Kit (Zymo
Research, Irvine, CA, USA), and were hybridized with the Illumina Human Methylation27
BeadChip (Illumina, Inc., San Diego, CA, USA), according to the manufacturer’s
instructions. After hybridization, allele-specific single-base extension and x-staining were
performed on the BeadChip, and fluorescent signals were acquired with the Bead Array
Reader (Illumina). The data from these images were analyzed using BeadStudio Methylation
Module (Illumina), and the relative level of methylation (β) was calculated as the ratio of
methylated-locus signal to total locus signal intensity.
Bioinformatics analysis
The relative level of methylation (β value) ranges between 0 and 1 with values close to 0
indicating no methylation and values close to 1 indicating presence of methylation. The raw
data was quantile normalized84 among the 24 samples and differential methylation was
tested using a paired moderated t-test.85 A given locus was deemed significant if its False
Discovery Rate86 adjusted p-value (called q-value) was less than 0.05 and the difference in
average β values between the two groups was 0.2 β units or more. Differentially methylated
gene listswere interpreted using Gene Ontology (GO) terms explaining that they enrich
using an over-representation analysis87 implemented in the Bioconductor
(www.bioconductor.org) package GOStats.88 All analyses were performed using the R
statistical language (www.r-project.org).
Bisulfite DNA pyrosequencing
Based on the results obtained from the Infinium Methylation Assay, the methylation status
of LAG3, INCA1, and IL1B promoter regions was validated by bisulfite pyrosequencing.
Genomic DNA (500 ng) samples of MMo, FMo, dMϕ, and HC from an independent group
of pregnant women at term not in labor (n=6) were treated with bisulfite, and the samples
were purified using Zymogen DNA columns (Zymo Research). Bisulfite-treated DNA was
eluted in 20 μl of TE buffer (pH 8.0), and 1 μl was used for each PCR. PCR was performed
with 0.2 μM of forward and reverse primers, and the PCR product was immobilized to
Streptavidin Sepharose HP (Amersham Biosciences, Uppsala, Sweden). The Sepharose
beads containing the immobilized PCR product were purified, washed and denatured using a
0.2 M NaOH solution and rewashed using the Pyrosequencing Vacuum Prep Tool (Qiagen),
according to the manufacturer’s instructions. For pyrosequencing, 0.2 μM of sequencing
primers was annealed to the purified single-stranded DNA, and 10 μl of the PCR products
were sequenced by Pyrosequencing PSQ96 HS System (Biotage AB, Uppsala, Sweden),
according to the manufacturer’s instructions. The methylation status of each locus was
analyzed individually as a T/C SNP using QCpG software (Qiagen).
Real-time quantitative RT-PCR
The total RNA of monocytes and macrophages (n=5) was isolated using the RNeasy Mini
Kit (Qiagen). Reverse transcription was done using the ImpromII Reverse Transcription
System (Promega, Madison, WI, USA). All PCR analyses were carried out using TaqMan
assays (Applied Biosystems, Foster City, CA, USA) for DNMT1 (Hs00154749_m1),
DNMT3A (Hs01027166_m1), DNMT3B (Hs00171876_m1), INCA1 (Hs01652223_m1),
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and RPLPO (4326314E). PCR reactions were done using the 7500 Fast Real-Time PCR
System (Applied Biosystems).
Immunoblotting
Total proteins from monocytes and macrophages (n=4) were isolated using RIPA buffer
(Sigma-Aldrich) containing a protease inhibitor cocktail (Roche). Twenty μg of proteins
were subjected to 10 % SDS-polyacrylamide gel electrophoresis, and electro-transferred
onto nitrocellulose membranes. The membranes were blocked with 5% nonfat dry milk in
Tris-buffered saline containing 0.1% Tween 20, and probed overnight at 4°C with a rabbit
polyclonal anti-INCA1 (1:500 dilution; ProSci Inc, Poway, CA, USA) or a mouse
monoclonal anti-β-actin (1:5,000 dilution; Sigma-Aldrich). Horseradish peroxidase-
conjugated anti-rabbit or mouse IgG (Vector Laboratories, Burlingame, CA, USA) was used
as a secondary antibody, and signals were detected by chemiluminescence using
ChemiGlow West Reagents (Alpha Innotech Corporation, San Leandro, CA, USA).
Decidual macrophage culture with 5-Azacytidine treatment and BrdU incorporation assay
The dMϕ (n=5) were plated in 6-well plates at the density of 5 × 105 cells per well in
RPMI1640 (Invitrogen) media supplemented with 10 % FBS and antibiotics. The cells were
treated with 5-azacytidine (Sigma-Aldrich) at the concentration of 5, 10, or 50 μM for 3
days. The cells were then pulsed with BrdU (10 μM) for 1 h, and stained using a BrdU Flow
Kit (BD Bioscience), according to the manufacturer’s instructions. Briefly, the cells were
fixed and permeabilized with BD Cytofix/Cytoperm buffer, and incubated with BD
Cytoperm Plus buffer. The cells were then fixed again with BD Cytofix/Cytoperm Buffer,
followed by DNase (0.3 mg/ml) treatment for 1 h at 37°C. After staining with FITC-
conjugated anti-BrdU antibody, the cells were analyzed for BrdU uptake using BD LSR II
flow cytometry (BD Biosciences) equipped with BD FACSDiva software version 6.0. Total
events numbered 3,000.
Statistical analysis
Wilcoxon signed rank tests for related variables and the Mann-Whitney U test for
independent variables were performed using the SPSS version 15.0 (SPSS Inc, Chicago, IL,
USA). All p-values were two-sided, and a value of p<0.05 was considered to be statistically
significant.
Results
Purity of isolated monocytes and macrophages
The purity of monocytes and macrophages isolated by cell sorter for microarray and
pyrosequencing was higher than 60.0% in all samples analyzed (Figure 1). The median of
purity was 99.4% (96.5–100%) for MMo, 98.8% (98.4–99.3%) for FMo, 93.7% (60.0–
99.3%) for dMϕ, and 87.5% (69.4–92.3%) for HC, respectively. The median of purity for
monocytes and macrophages isolated by MACS column for qPCR, immunoblot, and
decidual cell culture was 90.6% (76.7–94.5%) for MMo, 79.1% (46.9–93.3%) for FMo,
70.8% (52.5–85.7%) for dMϕ, and 73.9% (51.1–93.9%) for HC, respectively.
DNA methylation patterns: maternal vs. fetal monocytes and decidual macrophages vs.
Hofbauer cells
The majority of 27,551 annotated loci on the Illumina Infinium Methylation bead-array
showed an absence of methylation (Figure 2A: the left peak near 0.0), with about 9% of all
loci showing a methylation level β above 0.8 in each sample (Figure 2A: the right peak). An
unsupervised analysis of methylation levels showed clustering of the samples according to
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the cell populations studied: MMo, FMo, dMϕ, and HC (Figure 2). The basic comparisons
of the array data were done according to the host type (Maternal vs. Fetal) and the cell type
(Monocytes vs. Macrophages) (Figure 3). The data set is available in
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=tlyrpmsaqwkqwpe&acc=GSE31680.
In the comparisons between the mother and the fetus, 65 loci were differentially methylated
between MMo and FMo, whereas 266 loci were differentially methylated between dMϕ and
HC. Among the 65 differentially methylated loci, 25 loci and 40 loci were hyper- and hypo-
methylated in MMo compared to FMo. Interestingly, most of the immune response-related
genes such as SP2, LAG3, PGLYRP2, GBP1, and CX3CL1 were hypermethylated in FMo.
When the methylation patterns of dMϕ and HC were compared, 145 loci were
hypermethylated in dMϕ and 121 loci were hypermethylated in HC. Many of the immune
response-related genes such as EDG6, ADA, PGLYRP1, CST7, TRAF1, IL1B, PTGDR,
LAG3, and CD79A were found to be hypermethylated in HC. Other differentially
methylated loci included the genes related to cell cycle and apoptosis such as INCA1,
CASP8, and AIM2 (Table I). Of note, INCA1 and LAG3 were also among those 15 loci
whose differential methylation was found both in the comparisons between MMo and FMo
and between dMϕ and HC (Table II).
DNA methylation patterns: maternal monocytes vs. decidual macrophages and fetal
monocytes vs. Hofbauer cells
In the comparisons between blood monocytes and tissue macrophages, 199 loci were
differentially methylated between MMo and dMϕ, and 1,030 loci were differentially
methylated between FMo and HC (Table I). Of note, the majority [160/199 (80%)] of the
differentially methylated loci between MMo and dMϕ were also differentially methylated
between FMo and HC (Table II).
Gene Ontology analysis of differentially methylated genes revealed enrichment of 215
biological processes for MMo vs. dMϕ comparison and 52 processes for FMo vs. HC (Table
III). Most of the biological processes enriched in comparison between FMo vs. HC (51/52)
were also enriched in comparison between MMo and dMϕ, and they were related to the
variable aspects of immune responses, complement activation, cell adhesion, and
angiogenesis. The biological processes enriched in the comparison between MMo and dMϕ
included ion homeostasis, coagulation, and aminoglycan metabolic processes.
In the comparison between MMo vs. dMϕ, the genes encoding markers of classical
macrophage activation such as TLR9, IL1B, IL12RB2, CD48, and FGR were
hypermethylated in dMϕ, while those of alternative macrophage activation markers such as
CCL13, CCL14, A2M, HNMT, and IL10 were hypomethylated. The results suggested that
the anti-inflammatory property of human dMϕ is partly associated with its DNA methylation
pattern. The comparison of FMo vs. HC also demonstrated hypermethylation of the genes
encoding markers of classical macrophage activation such as TLR9, IL1B, IL12RB2, CD48,
and FGR in HC, whereas the genes encoding alternative macrophage activation markers
such as CCL2, CCL13, CCL14, CD209, and A2M were hypomethylated in HC.
Of note, two key enzymes, DNMT1 and DNMT3B, involved in DNA methylation were also
among the differentially methylated loci between FMo and HC.
Confirmation of CpG methylation of specific genes: LAG3, INCA1, IL1B
Three genes (LAG3, INCA1, IL1B) were selected for further validation of the methylation
status in each type of cells. LAG3 and INCA1 were differentially methylated between
maternal and fetal cells (MMo vs. FMo and dMϕ vs HC; Table IIA), and IL1B was found to
be differentially methylated between the blood monocyte and the tissue macrophage both in
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the mother and the fetus (Table IIB). Three CpG sites of each gene for bisulfite
pyrosequencing were chosen from the region interrogated by methylation microarray, and
the sequencing results of the three genes correlated with the microarray data. As shown in
Figure 4A, the methylation percentages of the LAG gene in MMo and dMϕ were lower than
those in FMo and HC, respectively (p<0.05 for each). The median of methylation
percentages was 59.5% for MMo, 82.8% for FMo, 60.2% for dMϕ, and 82.0% for HC. The
degree of methylation across three CpG sites of the INCA1 promoter region was also
confirmed to be higher in MMo (61.3%) than in FMo (45.3%), and in dMϕ (35.1%) than in
HC (8.7%), respectively (p<0.05 for each, Figure 4B). For IL1B, which was found to be
differentially methylated between monocyte and macrophage in the microarray analysis, the
median of methylation percentages was 31.1% for MMo, 51.9 % for dMϕ, 30.4% for FMo,
and 69.4% for HC, also confirming the microarray data (Figure 4C).
DNMT expression in blood monocytes, decidua, and chorionic villi
As DNMT1 and DNMT3B were among the differentially methylated loci between FMo and
HC in the microarray analysis and as they are major methyltransferases, we evaluated
mRNA expression levels of DNA methyltransferases (DNMT), DNMT1, DNMT3A, and
DNMT3B by quantitative RT-PCR using RNA samples from MMo, FMo, dMϕ, and HC.
mRNA expressions of DNMT1, DNMT3A, and DNMT3B were significantly lower in dMϕ
when compared to MMo and HC. DNMT1 mRNA expression in MMo was higher than that
of FMo (p<0.05 for each, Figure 5). The data suggested that the differences in the
methylation patterns of the cells tested are partly associated with the expression of DNMTs.
Increased expression of INCA1 mRNAby 5-azacytidine
Based on the microarray and pyrosequencing data, we further studied the effects of 5-
azacytidine induced demethylation on the mRNA expression of INCA1 (inhibitor of CDK
interacting with cyclin A1). INCA1 was hypermethylated in MMo or dMϕ and
hypomethylated in FMo or HC. Quantitative RT-PCR and immunoblotting were used to
confirm expression levels of INCA1 in monocytes and macrophages. INCA1 mRNA
expression was significantly down-regulated in dMϕ compared to HC (p<0.05); however,
there was no significant difference between MMo and FMo (Figure 6A). This seemed to be
due to a relatively small difference in the extent of DNA methylation between MMo and
FMo. INCA1 protein expression was also significantly lower in dMϕ than in HC as well as
in MMo than FMo (Figure 6B).
The treatment of isolated dMϕ with 5-azacytidine (10 nM) for 3 days significantly increased
INCA1 mRNA expression by 3.1 fold (p<0.05, Figure 6C). Because INCA1 is an inhibitor
of cell cycle progression,89, 90 we further studied the effect of the INCA1 methylation on the
proliferation of macrophages by BrdU labeling. Following the treatment with 5-azacytidine
for 3 days, the dMϕ were pulsed with BrdU. Flow cytometric evaluation demonstrated
decreased BrdU labeling in dMϕ with 5-azacytidine treatment in a dose-dependent manner
(p<0.05, Figure 6D).
Discussion
Monocytes and macrophages are important in the immunological interaction between the
mother and the fetus.91, 92 We investigated the methylome of blood monocytes and tissue
macrophages at the feto-maternal interface. The principal findings of this study are: 1) There
are distinct differences in the DNA methylation patterns between maternal cells and fetal
cells (MMo vs. FMo; dMϕ vs. HC), and the majority of differentially methylated genes
related to immune response are hypermethylated in the fetal cells; 2) The methylation
patterns of monocytes and macrophages are also quite different (MMo vs. dMϕ; FMo vs.
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HC), and the differential methylation pattern is more prominent between FMo and HC; 3)
Gene Ontology analysis of differentially methylated genes demonstrates significant
enrichment of many biological processes associated with immune responses in monocyte vs.
macrophage comparisons; 4) Pyrosequencing confirmed microarray results of three genes
tested (LAG3, INCA1, IL1B); 5) mRNA expression of DNMT1, DNMT3A, and DNMT3B
was significantly lower in dMϕ compared to HC; and 6) Treatment of dMϕ with 5-
azacytidine significantly increased mRNA expression of INCA1 with a concomitant
decrease in BrdU labeling.
DNA hypermethylation in fetal monocytes relevant to their impaired immune responses
Hypermethylation of the genes related to immune response in FMo compared to MMo
indicates that DNA methylation contributes to decreased immune response capacity of FMo
compared to MMo. The results are quite consistent with the gene expression data in a recent
transcriptome study of adult peripheral monocytes and umbilical cord blood monocytes.
Jiang et al have shown differential increases in gene expression between adult monocytes
and cord blood monocytes activated by lipopolysaccharides including cytokines,
chemokines, transcription factors, signal transduction, apoptotic regulation, and cell
structure.93 A previous study on relatively impaired responses of neonatal monocytes and
macrophages to multiple Toll-like receptor ligands also supports immature functional
capacity of neonatal monocytes compared to that of adult monocytes.94 An additional
possible explanation for differential methylation between FMo and MMo may be age-related
DNA methylation changes.95 The CD34+ hematopoietic progenitor cells from adult
peripheral blood showed differential methylation patterns compared to those from cord
blood80 and age-related DNA methylation changes are tissue-specific.95
DNA methylation during monocyte-macrophage differentiation
The present study clearly demonstrates distinct changes of DNA methylation during
monocyte-macrophage differentiation. The differences are more profound between FMo and
HC. The dMϕ and HC are deployed at the immunologically sensitive location: the feto-
maternal interface where an enhanced pro-inflammatory response can be detrimental to the
maintenance of pregnancy. Therefore, hypermethylation of certain genes encoding classical
activation markers and hypomethylation of a subset of gene-encoding alternative activation
markers of macrophages in dMϕ compared to MMo and in HC compared to FMo are
biologically quite relevant. DNA methylation seems to contribute to the anti-inflammatory
phenotype of dMϕ and HC. Gustafsson et al compared the transcriptome of CD14+
macrophages isolated from first trimester decidual tissue and peripheral blood monocytes.
Their study also has shown that the expression of the genes encoding alternative
macrophage activation markers such as CCL18 and CD209 is higher in dMϕ. Therefore,
dMϕ displays an anti-inflammatory phenotype compared to maternal blood monocytes.96 Of
note, their observation of increased expression of alpha-2-macroglobulin (A2M) in dMϕ is
consistent with the hypomethylation of this gene in this study, whereas decreased
expressions of asialoglycoprotein receptor 2 (ASGR2) and intercellular adhesion molecule 3
(ICAM3) are relevant with the hypermethylation of these genes in dMϕ. In addition to the
differential methylation of CpG sites, the M2-macrophage phenotype is epigenetically
regulated by chromatin remodeling following reciprocal changes in histone H3 lysine-4 and
histone H3 lysine-27 methylation.97 Our data is also consistent with recent observations on
the expression of selected molecules associated with macrophage polarization in HC.98, 99
Studies have shown that M2 markers such as DC-SIGN, CD163, and mannose receptor/
CD206 are detectable in HC but not in M1 markers (CX3CR1, IL7R, CCR7). Expression of
different combinations of M2 markers in dMϕ and HC which do not precisely match the
transcriptional profile of in vitro generated M2 macrophages also suggests the potential
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importance of the tissue microenvironment during monocyte to macrophage
differentiation.100, 101
A more profound difference in the DNA methylome between FMo and HC than between
MMo and dMϕ has biological implications. The origin of placental HC has been
controversial. It has been proposed that they derive from chorionic mesenchymal cells in the
villous stroma before the formation of villous capillaries,50, 51 while mobilization of blood
monocytes becomes the main route after the development of capillaries102 Therefore, HC
might represent a heterogeneous population of cells in the context of histogenesis. Our
observation of transdifferentiation of myofibroblasts into macrophages in the chorionic
mesoderm of the reflected chorion also supports that HC can differentiate from chorionic
mesenchymal cells.103 Furthermore, HC can normally proliferate, or in response to
biological stimuli such as inflammation64, 104 and pro-inflammatory cytokines such as IL-6,
would confer more chances of DNA methylation by changing gene expression patterns and
increasing expression of methyltransferase.105 Hypomethylation of INCA1 in HC compared
to dMϕ may also in turn contribute to the difference in the proliferative potential of these
fetal and maternal cells.
Differential regulation of DNA methyltransferase expression
This study also reports an interesting feature of the regulation of DNA methyl transferase
expression. DNMT1 and DNMT3B were among differentially methylated loci between FMo
and HC, and their mRNA expressions in dMϕ were lower than those in MMo and HC,
which in turn could modify overall methylation patterns of the cells studied. DNMTs have
two types of actions. DNMT1 is responsible for the maintenance of DNA methylation status,
while DNMT3A and DNMT3B are important for de novo methylation.72, 73 DNMT1 is
expressed ubiquitously whereas DNMT3A and DNMT3B have tissue-specific expression
patterns.106 Promoter methylation of DNA methyltransferases themselves may have a
broader impact on methylation patterns, and hypomethylation of DNMT3B was
demonstrated in glial tumors.107 We also demonstrated that differential DNA methylation
patterns have biological significance by showing the effects of INCA1 in dMϕ.
Limitations of this study
There are limitations to this study. First, the samples used for the analysis in the present
study were obtained from normal pregnant women at term, and the data related to pathologic
pregnancies are not available. Intra-amniotic infection by microbial invasion of the amniotic
cavity is a leading cause of preterm birth108–111 and elicits a robust acute inflammatory
response of the fetus.2, 60, 61, 112–120 Furthermore, the process is associated with an elevation
of the amniotic fluid concentrations of cytokines and chemokines such as macrophage
migration inhibitory factor and monocyte chemotactic protein-1.2, 121–123 The fetal
chorionic mesenchymal cells also acquire macrophage phenotype in the presence of intra-
amniotic infection and chorioamnionitis.103 Therefore, the biological significance of DNA
methylation of fetal and maternal monocytes and macrophages during intra-amniotic
infection needs to be further studied. The data also might not represent the methylome of
dMϕ or HC in the early gestational period. It is well-known that the number of HC decreases
with advancing gestation.124 Considering the duration of gestation, it is very likely that
methylation patterns of macrophages change across gestation. Houser et al have recently
demonstrated that there are two different populations of CD14+ macrophages according to
the expression level of CD11c (high vs. low) in the first trimester decidual tissues with
different functional implications in lipid metabolism, inflammation, and tissue growth.125
Therefore, it is possible that different subpopulations of macrophages were analyzed
together in our analysis.
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Conclusions
We report the DNA methylome of maternal and fetal monocytes and macrophages at the
feto-maternal interface for the first time. The distinct nature of DNA methylation patterns in
each subset of cells strongly suggests that epigenetic regulation of multiple genes is at the
core of functional diversification of the critical players in maternal and fetal immune
interaction during pregnancy. Particularly, DNA methylation seems to be a part of the
machinery conferring an anti-inflammatory phenotype to the macrophages at the feto-
maternal interface.
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Figure 1.
Identification of isolated monocytes and macrophages. (A) Immunoflourescent staining of
CD14 (green) positive sorted maternal monocytes (MMo), Fetal monocytes (FMo), decidual
macrophages (dMϕ) and Hofbauer cells (HC). The nuclei are stained with DAPI (blue).
Sorted cells show mononuclear morphology. (B) The purity of isolated cells for methylation
microarray by flow sorting was more than 80 % in each of MMo, FMo, dMϕ, and HC.
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Figure 2.
Methylation microarray analysis. (A) The distribution of loci methylation β values is shown
for each of the 24 samples. The peaks near β=0 illustrates that most of loci are un-
methylated in each sample, while the peaks near β=1 show that there is a sizable portion of
loci with high methylation β values in each sample. A principal component analysis (PCA)
plot (B) and a heat map (C) generated with data from 6 pairs of maternal monocytes (MMo,
gray), fetal monocytes (FMo, blue), decidual macrophages (dMϕ, black) and Hofbauer cells
(HC, green) show a clear segregation among the cell groups. The PCA plot (B) uses the data
from all loci, while the loci chosen for the heat map (C) are the top 200 ones varying the
most across all 24 samples (unbiased filtering) as described elsewhere.126
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Figure 3.
Venn diagram summary of differentially methylated loci between the groups. Differentially
methylated loci were using a FDR cut-off of 5% and average DNA methylation difference
(Δβ)>0.2. (A) Division of maternal vs. fetal groups. 65 loci were differentially methylated
between maternal monocytes (MMo) and fetal monocytes (FMo), and 266 loci were
differentially methylated between decidual macrophages (dMϕ) and Hofbauer cells (HC).
Fifteen loci were shared between each comparison. (B) Division of blood monocytes vs.
tissue macrophages. One hundred ninety-nine loci were differentially methylated between
MMo and dMϕ, and 1,030 loci were listed for differentially methylated genes between FMo
and HC. One hundred sixty loci were overlapped between each comparison.
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Figure 4.
Bisulfite pyrosequencing results of (A) LAG3, (B) INCA1 and (C) IL-1β in 6 samples of
genomic DNAs from maternal monocytes (MMo), fetal monocytes (FMo), decidual
macrophages (dMϕ) and Hofbauer cells (HC). Bisulfite sequencing was performed across 3
CpG sites of each gene chosen from the region interrogated by methylation microarray, and
the average percentages of methylation are well-correlated with microarray data. *p<0.05.
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Figure 5.
mRNA expressions of DNA methyltransferases by qRT-PCR show distinguished patterns in
maternal monocytes (MMo), fetal monocytes (FMo), decidual macrophages (dMϕ), and
Hofbauer cells (HC). The DNMTs mRNA expressions were normalized on the content of
RPLPO for each. *p<0.05, n=5.
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Figure 6.
Differential INCA1 expression in monocytes or macrophages by function of DNA
methylation. (A) qRT-PCR of INCA1 transcripts of maternal monocytes (MMo), fetal
monocytes (FMo), macrophages from decidua (dMϕ), and Hofbauer cells (HC). mRNA
expression of INCA1 is significantly down-regulated in dMϕ than in HC. The INCA1
mRNA expressions were normalized on the content of RPLPO. *p<0.05, n=5. (B) Western
blot of INCA1 of total proteins from columned MMo, FMo, dMϕ, and HC shows that
protein expression of INCA1 is higher in HC than in dMϕ, n=4. (C) qRT-PCR of INCA1
mRNA expression following treatment of 10 μM of 5-Azacytidine for 3 days to dMϕ.
mRNA expression of INCA1 was increased in dMϕ exposed to 5-Azacytidine. The INCA1
mRNA expressions were normalized on the content of RPLPO. *p<0.05, n=5. (D) BrdU
pulse labeling detection in 5-Azacytidine treated dMϕ. After treatment of 5-Azacytidine (0,
5, 10, or 50 μM), macrophages were pulsed with BrdU (10 μM) for 1 h, and stained with
anti BrdU antibody. The percentages of BrdU positive cells were measured by FACS. BrdU
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labeling decreased with 5-azacytidine treatment in a dose-dependent manner. *p< 0.05 vs.
control (0 μM), n=4.
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Table III
Top 20 biological processes enriched in monocyte vs. macrophage comparison
Biologic Process # Enriched Genes/# Genes in GO q-value
MMo vs. dMϕ
defense response 34/477 3.80E-14
immune response 32/522 1.46E-11
immune system process 35/750 1.48E-09
response to wounding 25/389 2.92E-09
inflammatory response 21/268 3.25E-09
acute inflammatory response 12/65 4.05E-09
response to external stimulus 29/615 5.44E-08
response to stimulus 56/2024 5.93E-08
response to stress 40/1142 7.34E-08
regulation of response to stimulus 16/215 1.16E-06
positive regulation of immune system process 12/130 7.32E-06
regulation of immune response 12/130 7.32E-06
extracellular region 43/1425 1.26E-05
leukocyte mediated immunity 10/87 1.10E-05
cell activation 15/233 1.70E-05
regulation of leukocyte mediated immunity 7/36 2.08E-05
positive regulation of response to stimulus 11/121 2.32E-05
lymphocyte mediated immunity 9/78 3.61E-05
activation of immune response 8/58 3.75E-05
immune effector process 11/130 4.05E-05
FMo vs. HC
immune response 76/522 8.10E-09
defense response 71/477 8.10E-09
immune system process 94/750 4.16E-08
response to wounding 58/389 3.35E-07
response to external stimulus 79/615 3.35E-07
inflammatory response 45/268 5.33E-07
acute inflammatory response 18/65 2.29E-05
response to stimulus 179/2024 1.09E-04
activation of plasma proteins during acute inflammatory response 12/33 1.09E-04
humoral immune response 16/61 1.95E-04
complement activation 11/32 5.26E-04
innate immune response 22/118 8.34E-04
cell adhesion 64/572 8.36E-04
biological adhesion 64/572 8.36E-04
activation of immune response 14/58 1.83E-03
complement activation, classical pathway 9/25 2.00E-03
positive regulation of immune response 17/83 2.03E-03
immune effector process 22/130 2.75E-03
positive regulation of response to stimulus 21/121 2.75E-03
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Biologic Process # Enriched Genes/# Genes in GO q-value
leukocyte mediated immunity 17/87 3.14E-03
Am J Reprod Immunol. Author manuscript; available in PMC 2013 July 01.
